Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Terminated 4Completed 4Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other 3Thoracic 1

Conditions

Neoplasms 2Constipation 2Pain 1Opioid-Induced Constipation 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Interventional × naloxegol × Clear all
NCT03087708 2025-07-17

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Terminated
50 enrolled 24 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02745353 2019-12-09

Naloxegol in Cancer Opioid-Induced Constipation

University of California, San Diego

Phase 2 Terminated
7 enrolled 9 charts
Other

Constipation, Neoplasms

NCT02839889 2019-03-05

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Hospice of Henderson County, Inc.

Phase 4 Terminated
12 enrolled 33 charts
Other

Constipation, Neoplasms, Pain

NCT01384292 2015-06-01

Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

AstraZeneca

Phase 3 Terminated
14 enrolled 7 charts
Other

Cancer Pain, Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡